综合代谢面板市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

综合代谢面板市场按测试类型(蛋白质、肾脏测试、电解质、肝功能测试、葡萄糖和其他测试)、疾病(肾脏疾病、糖尿病、肝病和其他疾病)、最终用户(点-护理中心和实验室)和地理(北美、欧洲、亚太、中东和非洲以及南美)。该报告提供了上述部分的价值(以百万美元计)。

市场快照

Comprehensive Metabolic Panel Market
Study Period: 2018-2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 7.2 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

预计在 2021-2026 年的预测期内,综合代谢面板市场的复合年增长率为 7.2%。市场的主要驱动力是人们对疾病的早期诊断和治疗意识的增强以及慢性病患病率的增加。此外,医疗点技术和诊断技术的进步预计将在未来几年推动市场增长。

随着 COVID-19 患者的增加,检测在全球范围内扩大,这刺激了正在进行的血液检测的增加,卫生官员预计 COVID-19 患者的数量将显着增加。因此,随着 COVID-19 患病率的增加,对血液检测的需求也随之增加,这进一步提振了整体市场。

根据国际糖尿病联合会的数据,2019 年约有 4.63 亿成年人患有糖尿病,预计到 2045 年将达到 7 亿人。糖尿病负担的增加以及政府和其他组织为提高民众认识所做的努力是预计将在预测期内提振市场。

根据 2018 年加州大学董事会的数据,仅在美国每年就有近 750,000 名患者,这种疾病不成比例地影响了该国的少数族裔和低收入患者。估计还报告说,全世界约有 200 万人患有终末期肾病 (ESRD),被诊断患有该疾病的患者人数继续以每年 5-7% 的速度增长。台湾、日本、墨西哥、美国和比利时等国家目前的 ESRD 患病率最高。因此,肾病、糖尿病和肝病等慢性病患病率的增加以及人们对这些疾病的早期诊断的重视是导致综合代谢面板 (CMP) 市场增长的因素。

对早期检测和这些测试更快结果的即时检测需求的增加是导致市场增长的其他一些因素。

报告范围

根据报告的范围,综合代谢小组是一组血液测试,可提供有关不同体液的信息,有助于诊断各种疾病。该测试是初步测试,其结果表明肝脏疾病、肾衰竭或糖尿病。大多数血液检查只需几分钟,建议患者禁食 10 到 12 小时以获得正确的测试结果。综合代谢面板市场按测试类型(蛋白质、肾脏测试、电解质、肝功能测试、葡萄糖和其他测试)、疾病(肾脏疾病、糖尿病、肝脏疾病和其他疾病)、最终用户(点-护理中心和实验室)和地理(北美、欧洲、亚太、中东和非洲以及南美)。该报告提供了上述部分的价值(以百万美元计)。

By Test Type
Proteins
Kidney Tests
Electrolytes
Liver Function Tests
Glucose
Other Test Types
By Disease
Kidney Diseases
Diabetes
Liver Diseases
Other Diseases
By End User
Point-of-care Centers
Laboratories
Geography
North America
United States (By Test Type, Disease, and End User)
Canada (By Test Type, Disease, and End User)
Mexico (By Test Type, Disease, and End User)
Europe
Germany (By Test Type, Disease, and End User)
United Kingdom (By Test Type, Disease, and End User)
France (By Test Type, Disease, and End User)
Italy (By Test Type, Disease, and End User)
Spain (By Test Type, Disease, and End User)
Rest of Europe (By Test Type, Disease, and End User)
Asia-Pacific
China (By Test Type, Disease, and End User)
Japan (By Test Type, Disease, and End User)
India (By Test Type, Disease, and End User)
Australia (By Test Type, Disease, and End User)
South Korea (By Test Type, Disease, and End User)
Rest of Asia-Pacific (By Test Type, Disease, and End User)
Middle-East and Africa
GCC (By Test Type, Disease, and End User)
South Africa (By Test Type, Disease, and End User)
Rest of Middle-East and Africa (By Test Type, Disease, and End User)
South America
Brazil (By Test Type, Disease, and End User)
Argentina (By Test Type, Disease, and End User)
Rest of South America (By Test Type, Disease, and End User)

Report scope can be customized per your requirements. Click here.

主要市场趋势

糖尿病部分预计在预测期内以健康的速度增长

糖尿病是增长最快的疾病之一,它正在扩大即时 (PoC) CMP 测试的患者群体。预计糖尿病和心血管疾病和其他目标疾病的日益流行将在预测期内推动对 CMP 测试的需求。

根据 2019 年国际糖尿病联盟的数据,2019 年有超过 4.63 亿成年人(20-79 岁)患有糖尿病,到 2045 年,这一数字可能会上升到 7 亿。超过 2000 万活产婴儿,即每 6 个活产婴儿中就有 1 个在怀孕期间受到糖尿病的影响。其中,大约 10-15% 的人口患有 1 型糖尿病。肾病、糖尿病和肝病等慢性病患病率的上升以及人们对这些疾病的早期诊断的重视是导致综合代谢面板 (CMP) 检测市场增长的一些因素。

预计即时诊断需求的增加和改变即时检测设备的新技术的出现将在预测期内提振市场。此外,在诊断中引入和实施数据驱动的解决方案以更好地评估健康状况正在进一步推动市场增长。

肾脏疾病领域也占有显着份额。这一份额归因于肾脏疾病的日益流行以及人们对早期诊断的日益重视。由于久坐不动的生活方式、改变的饮食习惯以及全球糖尿病患者的增加等因素,预计该细分市场在此期间将以显着的速度增长。

Estimated Number of People With Diabetes, in Million, 2019-2045

预计北美在预测期内将以显着的增长率增长

由于完善的医疗保健基础设施的不断增长、主要参与者的存在以及大量患者群体的存在,预计北美将在此期间增长。

随着 COVID-19 的增加,已经对血液进行了广泛的检测,而这种检测的增加刺激了北美地区对综合代谢面板市场的整体需求。

慢性肾病(CKD)已成为美国的一个公共卫生问题。根据美国疾病控制与预防中心 2019 年的数据,慢性肾脏病 (CKD) 存在于 15% 的美国成年人中,大约 3700 万人患有 CKD。与 45-64 岁 (13%) 或 18-44 岁 (7%) 的人群相比,CKD 在 65 岁或以上的人群 (38%) 中更常见。与男性 (12%) 相比,CKD 在女性 (15%) 中更常见。肾病、糖尿病和肝病等慢性病患病率的上升是导致综合代谢面板 (CMP) 检测市场增长的一些因素。

发现糖尿病扩大了床旁 (PoC) CMP 测试的患者池。糖尿病和高血压被发现是成人 CKD 的主要原因。糖尿病的其他危险因素包括心脏病、肥胖、CKD 家族史、肾脏损伤史和年龄较大。此外,有利的报销政策和政府支持预计将有助于该地区的市场增长。

Comprehensive Metabolic Panel Market- Growth Rate By Region

竞争格局

综合代谢面板市场具有中等竞争力,市场上有本地和国际参与者。公司正在专注于合作并扩展到新的地区以加强其市场份额。在该市场运营的主要参与者包括 Quest Diagnostics、Laboratory Corporation of America Holdings、ARUP Laboratories、Synlab Hrvatska 和 UNIPATH 等。这些主要参与者越来越关注战略举措,例如产品发布和开发、并购、许可合作伙伴关系和共同开发交易,使这个市场竞争激烈。

竞争格局

综合代谢面板市场具有中等竞争力,市场上有本地和国际参与者。公司正在专注于合作并扩展到新的地区以加强其市场份额。在该市场运营的主要参与者包括 Quest Diagnostics、Laboratory Corporation of America Holdings、ARUP Laboratories、Synlab Hrvatska 和 UNIPATH 等。这些主要参与者越来越关注战略举措,例如产品发布和开发、并购、许可合作伙伴关系和共同开发交易,使这个市场竞争激烈。

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Growing Awareness Regarding Early Diagnosis and Treatment of Diseases

      2. 4.2.2 Increasing Prevalence of Chronic Diseases

    3. 4.3 Market Restraints

      1. 4.3.1 Lack of Skilled Professionals

      2. 4.3.2 Stringent Regulatory Policies

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Test Type

      1. 5.1.1 Proteins

      2. 5.1.2 Kidney Tests

      3. 5.1.3 Electrolytes

      4. 5.1.4 Liver Function Tests

      5. 5.1.5 Glucose

      6. 5.1.6 Other Test Types

    2. 5.2 By Disease

      1. 5.2.1 Kidney Diseases

      2. 5.2.2 Diabetes

      3. 5.2.3 Liver Diseases

      4. 5.2.4 Other Diseases

    3. 5.3 By End User

      1. 5.3.1 Point-of-care Centers

      2. 5.3.2 Laboratories

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States (By Test Type, Disease, and End User)

        2. 5.4.1.2 Canada (By Test Type, Disease, and End User)

        3. 5.4.1.3 Mexico (By Test Type, Disease, and End User)

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany (By Test Type, Disease, and End User)

        2. 5.4.2.2 United Kingdom (By Test Type, Disease, and End User)

        3. 5.4.2.3 France (By Test Type, Disease, and End User)

        4. 5.4.2.4 Italy (By Test Type, Disease, and End User)

        5. 5.4.2.5 Spain (By Test Type, Disease, and End User)

        6. 5.4.2.6 Rest of Europe (By Test Type, Disease, and End User)

      3. 5.4.3 Asia-Pacific

        1. 5.4.3.1 China (By Test Type, Disease, and End User)

        2. 5.4.3.2 Japan (By Test Type, Disease, and End User)

        3. 5.4.3.3 India (By Test Type, Disease, and End User)

        4. 5.4.3.4 Australia (By Test Type, Disease, and End User)

        5. 5.4.3.5 South Korea (By Test Type, Disease, and End User)

        6. 5.4.3.6 Rest of Asia-Pacific (By Test Type, Disease, and End User)

      4. 5.4.4 Middle-East and Africa

        1. 5.4.4.1 GCC (By Test Type, Disease, and End User)

        2. 5.4.4.2 South Africa (By Test Type, Disease, and End User)

        3. 5.4.4.3 Rest of Middle-East and Africa (By Test Type, Disease, and End User)

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil (By Test Type, Disease, and End User)

        2. 5.4.5.2 Argentina (By Test Type, Disease, and End User)

        3. 5.4.5.3 Rest of South America (By Test Type, Disease, and End User)

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Quest Diagnostics

      2. 6.1.2 Laboratory Corporation of America Holdings

      3. 6.1.3 Sonic Healthcare Limited

      4. 6.1.4 SYNLAB International GmbH

      5. 6.1.5 Charles River Laboratories Inc.

      6. 6.1.6 ARUP Laboratories

      7. 6.1.7 NeoGenomics Laboratories Inc.

      8. 6.1.8 Genoptix Inc.

      9. 6.1.9 CENTOGENE AG

      10. 6.1.10 UNIPATH

      11. 6.1.11 Abbott Laboratories

      12. 6.1.12 Abaxis Inc. (Zoetis)

      13. 6.1.13 TCG Corp.

      14. 6.1.14 Scion Lab Services LLC

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Global Comprehensive Metabolic Panel Market market is studied from 2018 - 2026.

The Global Comprehensive Metabolic Panel Market is growing at a CAGR of 7.2% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Quest Diagnostics, Laboratory Corporation of America Holdings, ARUP Laboratories., Synlab Hrvatska, UNIPATH are the major companies operating in Global Comprehensive Metabolic Panel Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!